We Think Pediatrix Medical Group (NYSE:MD) Is Taking Some Risk With Its Debt
Pediatrix Upped to Buy by Jefferies, Free Cash Flow Cited
Jefferies Initiates Pediatrix Medical(MD.US) With Buy Rating, Announces Target Price $14
Jefferies Upgrades Pediatrix Medical to Buy From Hold
Buy Rating for Pediatrix Medical Group: Undervalued Stock With Strong Growth and Free Cash Flow Potential
Pediatrix Medical Group (NYSE:MD) Shareholders Have Endured a 63% Loss From Investing in the Stock Three Years Ago
Pediatrix Medical Group (MD)'s Technical Outlook Is Bright After Key Golden Cross
Why Is Pediatrix Medical Group (MD) Up 9.5% Since Last Earnings Report?
All You Need to Know About Pediatrix Medical Group (MD) Rating Upgrade to Strong Buy
Truist Financial Maintains Pediatrix Medical(MD.US) With Hold Rating, Announces Target Price $10
Truist Financial analyst David S Macdonald maintains $Pediatrix Medical(MD.US)$ with a hold rating, and sets the target price at $10.According to TipRanks data, the analyst has a success rate of 64.7%
Express News | Pediatrix Medical Group Inc : Truist Securities Raises Target Price to $10 From $8
Truist Adjusts Price Target on Pediatrix Medical Group to $10 From $8, Maintains Hold Rating
Insider Sale at Pediatrix Medical Group Inc (MD)
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD)
Pediatrix Medical Group: Cautious Hold Rating Amidst Financial Growth and Restructuring
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS)
UBS Adjusts Pediatrix Medical Group Price Target to $10.50 From $9, Maintains Neutral Rating
Pediatrix Medical Group Analyst Ratings
Express News | Pediatrix Medical Group Inc : Mizuho Raises Target Price to $10 From $9
Pediatrix Medical Group: Strong EBITDA Amidst Strategic Shifts, Yet Uncertainties Prompt Hold Rating